Literature DB >> 25147226

Familial tumoral calcinosis: a valuable vehicle for discovery.

Orson W Moe1.   

Abstract

Entities:  

Keywords:  FGF23; calcification; glycosylation; phosphate; tumoral calcinosis

Mesh：

Substances：

Year:  2014        PMID： 25147226      PMCID： PMC4240180          DOI： 10.1093/ndt/gfu270

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  30 in total

1.  The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study.

Authors:  Benjamin D Parker; Leon J Schurgers; Vincent M Brandenburg; Robert H Christenson; Cees Vermeer; Markus Ketteler; Michael G Shlipak; Mary A Whooley; Joachim H Ix
Journal:  Ann Intern Med       Date:  2010-05-18       Impact factor: 25.391

2.  FGF23: is it ready for prime time?

Authors:  Katherine Wesseling-Perry
Journal:  Clin Chem       Date:  2011-09-13       Impact factor: 8.327

Review 3.  Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism.

Authors:  Ming Chang Hu; Kazuhiro Shiizaki; Makoto Kuro-o; Orson W Moe
Journal:  Annu Rev Physiol       Date:  2013       Impact factor: 19.318

Review 4.  FGF23 and the parathyroid glands.

Authors:  Justin Silver; Tally Naveh-Many
Journal:  Pediatr Nephrol       Date:  2010-06-05       Impact factor: 3.714

5.  Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23.

Authors: 
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

6.  Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia.

Authors:  T Shimada; S Mizutani; T Muto; T Yoneya; R Hino; S Takeda; Y Takeuchi; T Fujita; S Fukumoto; T Yamashita
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

Review 7.  Is fibroblast growth factor 23 a harbinger of mortality in CKD?

Authors:  Jason R Stubbs; Steve Egwuonwu
Journal:  Pediatr Nephrol       Date:  2011-03-10       Impact factor: 3.714

Review 8.  Clinical assessment of phosphorus status, balance and renal handling in normal individuals and in patients with chronic kidney disease.

Authors:  Chou-Long Huang; Orson W Moe
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-07       Impact factor: 2.894

Review 9.  FGF23: a mature renal and cardiovascular risk factor?

Authors:  Carmine Zoccali; Mahmut Ilker Yilmaz; Francesca Mallamaci
Journal:  Blood Purif       Date:  2013-05-25       Impact factor: 2.614

10.  Lifetime incidence of CKD stages 3-5 in the United States.

Authors:  Morgan E Grams; Eric K H Chow; Dorry L Segev; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2013-04-06       Impact factor: 8.860
View more
  2 in total

Review 1.  Regulation of FGF23: Beyond Bone.

Authors:  Petra Simic; Jodie L Babitt
Journal:  Curr Osteoporos Rep       Date:  2021-11-10       Impact factor: 5.096

Review 2.  Juxta-articular tumoral calcinosis associated with the temporomandibular joint: a case report and concise review.

Authors:  Yang Sha; Kanglun Hong; Melvin Kang Ming Liew; Jing Li Lum; Raymond Chung Wen Wong
Journal:  BMC Oral Health       Date:  2019-07-09       Impact factor: 2.757
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.